Please assess the completion status of the following clinical trial:

Trial Title: PTNS for Female Patients Suffering From Multiple Sclerosis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Women with diagnosis for Multiple Sclerosis (Clinically isolated syndrome (CIS), relapsing remitting (RRMS), secondary progressive (SPMS), and/or primary progressive (PPMS)), 18 years of age or older~* Self-reported bladder symptoms \> 3 months~* Discontinued antimuscarinics/beta-3 agonists for \> 2 weeks, and remain off for the duration of the study~* Capable of giving informed consent~* Ambulatory and able to use toilet independently without difficulty~* Capable and willing to follow all study-related procedures~* If of childbearing age, agree to practice approved birth-control methods (oral contraceptives, condom barrier, injection, diaphragm or cervical cap, vaginal contraceptive ring, intrauterine device (IUD), implantable contraceptive, surgical sterilization (bilateral tubal ligation), vasectomized partner(s))~* Subject agrees not to start any new treatments for urinary symptoms (medication or otherwise) during the treatment and follow-up periods.~* Subject agrees to maintain a stable dose on all current medications throughout the treatment and follow-up period.~Exclusion Criteria:~* Pregnant or planning to become pregnant during study duration~* Botox (BTX) use in bladder or pelvic floor muscles within past 6 months~* Pacemakers or implantable defibrillators~* Current urinary tract infection~* Active use of neuromodulation in any other form. If patient has InterStim, must be turned off for 2 weeks for a washout period and remain off during the entirety of the study.~* Current use of Transcutaneous Electrical Nerve Stimulation (TENS) in pelvic region, back or legs~* Previous PTNS treatment~* Participation in any clinical investigation involving or impacting gynecologic, urinary, or renal function within past 4 weeks~Note: For the sake of preserving scientific integrity, one or more of the eligibility criteria have been left off the list posted while the trial is ongoing. A full list of eligibility criteria will be posted upon completion of the trial.

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Active PTNS (Type: ACTIVE_COMPARATOR): Once a week induction consisting of active PTNS treatments for 30 minutes for 12 consecutive weeks.
- Sham PTNS (Type: PLACEBO_COMPARATOR): Once a week induction consisting of Sham PTNS treatments for 30 minutes for 12 consecutive weeks.

Based on this trial design, predict the completion outcome and termination type (if applicable).